The Syneos Health Podcast | CNS Summit 2025 Series

Now in its second season, this exclusive podcast series—produced in collaboration with CNS Summit—features biopharma leaders sharing bold ideas, breakthrough innovations and what it takes to move smarter and faster for patients. 

Each episode explores the mindset and momentum behind today’s most transformative strategies. Listen in to stay ahead of what’s next in life sciences.

Scroll down to explore all episodes or tune in wherever you get your podcasts. 

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

Episode 1: Can Psychedelics Reshape Psychiatry? A Conversation with Kabir Nath, CEO, Compass Pathways 

Compass Pathways CEO Kabir Nath joins host, Dr. Alex Wise, Global Head of Neuroscience at Syneos Health, to discuss the clinical promise of psychedelics and what’s next for psychiatric innovation. 

What you’ll learn: 

- What’s driving the momentum behind psilocybin therapy
- Why investor confidence is growing in mental health biotech 
- How biopharma can better communicate the value of innovation 
- Kabir’s message to next-gen leaders in science and strategy